LV DNA, genome, and capsid are not required for DC activation and CD8+ T cell priming in vivo. LV DNA, genome, and capsid are not required for DC activation.

Slides:

Advertisements

Similar presentations

Dominant IL-21 expression in TFH cells correlate with B cell pathology in HIV-infected LNs. Dominant IL-21 expression in TFH cells correlate with B cell.

Advertisements

Identification of combination treatment–responsive effector/memory tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.

Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.

MP cells, but not pathogen-elicited effector CD4+ T lymphocytes, rapidly produce IFN-γ during T. gondii infection independently of pathogen antigens. MP.

Treg and Teff cell subsets show increased TCR overlap during colitis.

MP cells are generated from naïve cells in the periphery.

Expansion of Bacteroides species during colitis does not enhance TCR-specific T cell responses. Expansion of Bacteroides species during colitis does not.

Helicobacter species induce pTreg cell differentiation during homeostasis. Helicobacter species induce pTreg cell differentiation during homeostasis. (A)

LV envelope is responsible for DC activation.

Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation. Colonic Treg TCRs (CT2 and CT6) drive Teff cell development in inflammation.

FIP200 deficiency alters mitochondria activation and ROS production in T cells. FIP200 deficiency alters mitochondria activation and ROS production in.

Specific depletion of TFH and LCMV-specific CD4 T cells.

VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.

MP cells established in Rag γc KO mice are Toxoplasma antigen–unspecific T-bet+ population. MP cells established in Rag γc KO mice are Toxoplasma antigen–unspecific.

CD8α+ DC-deficient mice are highly susceptible to Lm infection in the absence of CD169+ macrophages. CD8α+ DC-deficient mice are highly susceptible to.

Antitumor effect of local cancer immunotherapy treatment toward distant B16F10 tumors. Antitumor effect of local cancer immunotherapy treatment toward.

Viral fusion is required for DC activation.

LV pseudotransduction delivers proteins and activates DCs.

Regulatory CD4+ T cell–derived IL-10 is important for B cell differentiation and the GC response. Regulatory CD4+ T cell–derived IL-10 is important for.

CD169+ macrophages mediate Lm translocation to the splenic T cell zones. CD169+ macrophages mediate Lm translocation to the splenic T cell zones. (A) Confocal.

LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.

FIP200 loss links to poor autophagy and high apoptosis in naïve T cells in tumor. FIP200 loss links to poor autophagy and high apoptosis in naïve T cells.

Human PBMC-derived MERS-CoV–specific T cells are multifunctional.

Resistance of CD141+ DCs to influenza virus in vivo in humanized mice.

VH usage of cross-reactive B cells induced by H5N1 or H7N9 vaccination

MP cells can mediate resistance in infectious models that induce TH1-type immunity. MP cells can mediate resistance in infectious models that induce TH1-type.

MP cells consist of rapidly proliferating CD5hi and relatively quiescent CD5lo cells, both of which require CD28 signaling for Ki67 expression. MP cells.

Tfr cells robustly secrete IL-10 after acute viral infection.

Tfr cell–derived IL-10 is important for B cell differentiation and the GC response. Tfr cell–derived IL-10 is important for B cell differentiation and.

T-bethi MP cells produce IFN-γ in response to IL-12.

Fig. 6 In utero injection of inflammatory cytokines or adoptive transfer of activated T cells leads to pregnancy loss. In utero injection of inflammatory.

Blood Tfr cells are lymphoid tissue–derived Tfr precursors.

BAP1 deficiency results in thymic atrophy and loss of thymocyte populations. BAP1 deficiency results in thymic atrophy and loss of thymocyte populations.

Fig. 4. Peanut-specific TH2A cells are specifically targeted during immunotherapy. Peanut-specific TH2A cells are specifically targeted during immunotherapy.

NCMs regulate T cell survival in TLOs via PD-L1.

Helicobacter species induce pTreg cell differentiation during homeostasis. Helicobacter species induce pTreg cell differentiation during homeostasis. (A)

MP cells are generated from naïve cells in the periphery.

Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.

Administration of necroptosis-targeting AAVs in conjunction within vivo promotes durable tumor clearance. Administration of necroptosis-targeting AAVs.

Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. (A)

Antigen-specific immune responses are enhanced in hypertension.

LV particles and VLPs contain human genomic DNA recognized by the host STING pathway. LV particles and VLPs contain human genomic DNA recognized by the.

APCs from hypertensive mice present antigens more efficiently.

Fig. 5 A competent Fc is required for the antitumor immune response.

MP cells, but not pathogen-elicited effector CD4+ T lymphocytes, rapidly produce IFN-γ during T. gondii infection independently of pathogen antigens. MP.

Microrobots with different cell-carrying capacities under different grid lengths (lg) and burr lengths (lb). Microrobots with different cell-carrying capacities.

BAP1 is required for homeostatic and antigen-driven expansion of peripheral T cells. BAP1 is required for homeostatic and antigen-driven expansion of peripheral.

Vaccine MN confer protective innate and adaptive immunity.

RAPTOR deficiency impairs the DN-to-DP transition in αβ T cell development. RAPTOR deficiency impairs the DN-to-DP transition in αβ T cell development.

MR1Ts recognized by the hpMR1+EC tetramer are more likely to be TRAV1-2−. MR1Ts recognized by the hpMR1+EC tetramer are more likely to be TRAV1-2−. PBMCs.

RORα deficiency in Tregs results in exaggerated skin inflammation in response to EC sensitization. RORα deficiency in Tregs results in exaggerated skin.

CD25 expression identifies two transcriptionally distinct subsets of very early effector cells. CD25 expression identifies two transcriptionally distinct.

Memory-biased TCRs induce weaker TCR signals than effector-biased TCRs in vitro. Memory-biased TCRs induce weaker TCR signals than effector-biased TCRs.

CD25 surface expression and TCR signal strength predict T helper differentiation and memory potential of early effector T cells in vivo. CD25 surface expression.

Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.

Fig. 2 In situ vaccination of CpG in combination with anti-OX40 antibody cures established local and distant tumors. In situ vaccination of CpG in combination.

BMS blocks functional responses in primary immune cells driven by IFNα

Tfr cells respond better to immunization with self-antigens than with foreign antigens. Tfr cells respond better to immunization with self-antigens than.

Fig. 3 Local Maraba treatment of TNBC tumors provides long-term systemic protection. Local Maraba treatment of TNBC tumors provides long-term systemic.

CD4+ memory T cells derived from either CD25hi or CD25lo effector cells respond robustly to secondary challenge. CD4+ memory T cells derived from either.

CD25 expression predicts effector and memory differentiation.

Colonic Treg TCRs react to MA Helicobacter species.

GPR55 regulates γδT cell egress from PP and homing of gut-tropic CD8 T cells to the small intestine. GPR55 regulates γδT cell egress from PP and homing.

Immune checkpoint molecule expression in primary and secondary tumors following radiotherapy. Immune checkpoint molecule expression in primary and secondary.

Regulation of antibacterial B cell responses in the peritoneal cavity via MyD88 signaling in FRCs. Regulation of antibacterial B cell responses in the.

Acute circadian disruption alters ILC3 cytokine secretion.

Meningeal γδ T cells are biased toward IL-17 production.

Fetal-derived γδ T cells infiltrate the meninges from birth.

Bb monocolonization enhances Treg population in the cLP.

CCR6 is dispensable for expansion of innate TCRαβ+ cells in oral candidiasis. CCR6 is dispensable for expansion of innate TCRαβ+ cells in oral candidiasis.

Presentation transcript:

LV DNA, genome, and capsid are not required for DC activation and CD8+ T cell priming in vivo. LV DNA, genome, and capsid are not required for DC activation and CD8+ T cell priming in vivo. (A) Wild-type mice received homologous prime-boost vaccination of SVGmu-pseudotyped LV-OVA with or without RTI or VLP-OVA (n = 8 mice per group). Representative FACS plots show OVA-tetramer+ cells gated on CD8+ T cells from the blood at 7 and 10 days after primary immunization (left). Graph depicts percentages of OVA-tetramer+ CD8+ T cells from the blood of immunized and unimmunized mice over time (black arrow, boost) (right). (B) Representative FACS plots show expression of CD62L and CD44 on OVA-tetramer+ CD8+ T cells from immunized mice compared with naïve CD8+ T cells from unimmunized mice at 7 days after boost (left). Graphs depict percentages of CD62Llo and CD44hi OVA-tetramer+ cells, with each symbol representing an individual mouse and horizontal bar indicating the mean (right). (C) Seven weeks after boost, mice were injected with 5 × 106 OVA-expressing E.G7 thymoma tumor cells and 5 × 106 EL4 (control) non–OVA-expressing EL4 thymoma tumor cells on opposing legs, and tumor sizes were measured. (D to F) Wild-type mice were homologously prime-boosted with LV-OVA, VLP-OVA, or capsid-less VLP-OVAΔgag. OVA-tetramer+ cells from the blood were analyzed as in (A) (n = 8 mice per group) at 7 days after boost (left) and over time (right) (D). CD62L and CD44 expression of OVA-tetramer+ CD8+ T cells from immunized mice compared with naïve CD8+ T cells from unimmunized mice at 7 days after boost were measured as in (B) (E). Mice were injected with tumor cells, as in (C), and tumor sizes were measured (F). (G) Wild-type mice were immunized with LV-OVA, LV encoding OVA carrying GFP (LV-GFPgene-OVAprotein), or VLP-OVA (n = 8 mice per group), and OVA-tetramer+ CD8+ T cells from the blood were measured over time. Statistical comparisons were made between the LV-GFPgene-OVAprotein– and VLP-OVA– or LV-OVA–immunized mice. Data are representative of two independent experiments (A to G). Results are shown as mean ± SEM (A, C, D, F, and G). P > 0.05; **P < 0.005; ***P < 0.001 (unpaired Student’s t test). Jocelyn T. Kim et al. Sci. Immunol. 2017;2:eaal1329 Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works